The Next Generation of Energy: Understanding Power Plans – What They Are and Why They Matter

Host of The Next Generation of Energy, Tyler Kern, spoke with Joe Piccirilli, CEO of RoseWater Energy, about power plans for specific projects – what they are and how they are implemented.

The conversation opened with a discussion of microprocessors and the importance of the electronic devices having consistent access to energy. Britannica defines a microprocessor as “any of a type of miniature electronic device that contains the arithmetic, logic and control circuitry necessary to perform the functions of a digital computer’s central processing unit.”

Whether we realize it or not, microprocessors permeate daily life. For instance, in the home, they can be found in a variety of devices, including washing machines, microwaves, dishwashers, refrigerators, hairdryers, electric toothbrushes and much more.

Piccirilli also noted the importance of consistent energy to ensure proper functionality of microprocessors. “As we continue to automate homes and businesses, we are loading them up with microprocessors,” he explained. “And, microprocessors want consistent voltage, consistent current — so consistent power in general. They certainly do not like power outages.”

Why does this matter? Sags and surges in energy can compromise longevity or cause complete failure altogether. Microprocessors impact virtually every aspect of our lives, so when they don’t work, the quality of life is severely impacted. The solution – power plans designed to meet the growing needs of advanced technology as well as the growing number of devices in our lives.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More